{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T15:42:53Z","timestamp":1784907773634,"version":"3.55.0"},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"52","license":[{"start":{"date-parts":[[2023,12,29]],"date-time":"2023-12-29T00:00:00Z","timestamp":1703808000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,12,29]]},"abstract":"<jats:sec>\n            <jats:title>Rationale:<\/jats:title>\n            <jats:p>Cancer with unknown primary site is a kind of disease that is difficult to deal with clinically, accounting for 2% to 9% of all newly diagnosed cancer cases. Here, we report such a case with pelvic metastatic squamous cell carcinoma of an unknown primary site and review the relevant literature.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Patient concerns &amp; Diagnoses:<\/jats:title>\n            <jats:p>A 43-year-old Chinese female patient was referred to our hospital and initially diagnosed as \u201cmalignant tumor of right adnexal area?, obstruction of right ureter, secondary hydronephrosis\u201d.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Interventions:<\/jats:title>\n            <jats:p>Thereafter cytoreductive surgery was performed which included a total hysterectomy, left adnexectomy, partial omentum resection, pelvic lymph node dissection, and para-aortic lymph node dissection. The primary lesion could not be identified by supplementary examination and postoperative pathology. The patient was diagnosed as pelvic metastatic squamous cell carcinoma whose primary site was unknown. To prevent a recurrence, we administered adjuvant chemotherapy for the patient.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Outcomes:<\/jats:title>\n            <jats:p>The patient was followed up after treatment, complete remission has been maintained for 72 months, and no recurrence or metastasis has been found.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Lessons:<\/jats:title>\n            <jats:p>Our case demonstrates that surgery combined with chemotherapy could be helpful for pelvic metastatic squamous cell carcinoma of unknown primary site.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000036796","type":"journal-article","created":{"date-parts":[[2024,1,9]],"date-time":"2024-01-09T16:05:24Z","timestamp":1704816324000},"page":"e36796","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":4,"title":["Pelvic metastatic squamous cell carcinoma of unknown primary site: A case report and brief literature review"],"prefix":"10.1097","volume":"102","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7419-6462","authenticated-orcid":false,"given":"Qi-Zhou","family":"Zhu","sequence":"first","affiliation":[{"name":"Department of Gynecological Oncology, Jiangxi Maternal and Child Health Hospital, Nanchang, Jiangxi, People\u2019s Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui-Juan","family":"Li","sequence":"additional","affiliation":[{"name":"Medical Department, Jiangxi Maternal and Child Health Hospital, Nanchang, Jiangxi, People\u2019s Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan-Qiang","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Gynecological Oncology, Jiangxi Maternal and Child Health Hospital, Nanchang, Jiangxi, People\u2019s Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Hong","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of Pathology, Jiangxi Maternal and Child Health Hospital, Nanchang, Jiangxi, People\u2019s Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuan-Yong","family":"Shu","sequence":"additional","affiliation":[{"name":"Department of Gynecological Oncology, Jiangxi Maternal and Child Health Hospital, Nanchang, Jiangxi, People\u2019s Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250503","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1007\/s12094-018-1899-z","article-title":"2018 consensus statement by the Spanish Society of Pathology and the Spanish Society of Medical Oncology on the diagnosis and treatment of cancer of unknown primary.","volume":"20","author":"Losa","year":"2018","journal-title":"Clin Transl Oncol"},{"issue":"Suppl 3","key":"R2-20250503","doi-asserted-by":"crossref","first-page":"iii11","DOI":"10.1093\/annonc\/mdg742","article-title":"Cancer of unknown primary: biological and clinical characteristics.","volume":"14","author":"Pavlidis","year":"2003","journal-title":"Ann Oncol"},{"key":"R3-20250503","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1002\/ijc.32482","article-title":"Cancer of unknown primary: Incidence rates, risk factors and survival among adolescents and young adults.","volume":"146","author":"Pavlidis","year":"2020","journal-title":"Int J Cancer"},{"key":"R4-20250503","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.critrevonc.2004.10.002","article-title":"Cancer of unknown primary (CUP).","volume":"54","author":"Pavlidis","year":"2005","journal-title":"Crit Rev Oncol Hematol"},{"key":"R5-20250503","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/nrc3646","article-title":"Cancer of unknown primary site: still an entity, a biological mystery and a metastatic model.","volume":"14","author":"Greco","year":"2014","journal-title":"Nat Rev Cancer"},{"key":"R6-20250503","doi-asserted-by":"crossref","first-page":"C70","DOI":"10.12968\/hmed.2019.80.5.C70","article-title":"Cancers of unknown primary.","volume":"80","author":"Tay","year":"2019","journal-title":"Br J Hosp Med (Lond)"},{"key":"R7-20250503","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21590","article-title":"Cancer statistics, 2020.","volume":"70","author":"Siegel","year":"2020","journal-title":"CA Cancer J Clin"},{"key":"R8-20250503","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1002\/jso.20099","article-title":"Unknown primary.","volume":"87","author":"Chorost","year":"2004","journal-title":"J Surg Oncol"},{"key":"R9-20250503","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/s12885-019-5274-4","article-title":"Identifying primary site of lung-limited Cancer of unknown primar based on relative gene expression orderings.","volume":"19","author":"Li","year":"2019","journal-title":"BMC Cancer"},{"key":"R10-20250503","doi-asserted-by":"crossref","first-page":"4814","DOI":"10.1002\/cam4.1689","article-title":"Cancer of unknown primary-Epidemiological trends and relevance of comprehensive genomic profiling.","volume":"7","author":"Binder","year":"2018","journal-title":"Cancer Med"},{"key":"R11-20250503","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.ejca.2013.08.009","article-title":"Population-based incidence, treatment and survival of patients with peritoneal metastases of unknown origin.","volume":"50","author":"Thomassen","year":"2014","journal-title":"Eur J Cancer"},{"key":"R12-20250503","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1148\/radiol.14141073","article-title":"Detection of occult primary tumors in patients with cervical metastases of unknown primary tumors: comparison of (18) F FDG PET\/CT with contrast-enhanced CT or CT\/MR imaging-prospective study.","volume":"274","author":"Lee","year":"2015","journal-title":"Radiology"},{"key":"R13-20250503","doi-asserted-by":"crossref","first-page":"e88","DOI":"10.1097\/RLU.0000000000001461","article-title":"PET\/MR outperforms PET\/CT in suspected occult tumors.","volume":"42","author":"Sekine","year":"2017","journal-title":"Clin Nucl Med"},{"key":"R14-20250503","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1200\/JCO.18.00771","article-title":"Randomized phase II trial comparing site-specific treatment based on gene expression profiling with carboplatin and paclitaxel for patients with cancer of unknown primary site.","volume":"37","author":"Hayashi","year":"2019","journal-title":"J Clin Oncol"},{"key":"R15-20250503","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.ejca.2018.02.021","article-title":"Comprehensive analysis of cancers of unknown primary for the biomarkers of response to immune checkpoint blockade therapy.","volume":"94","author":"Gatalica","year":"2018","journal-title":"Eur J Cancer"},{"key":"R16-20250503","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1080\/01443610701467812","article-title":"Unknown primary site of serous papillary adenocarcinoma involving inguinal, iliac and obturator lymph nodes co-existing with endometrial adenocarcinoma.","volume":"27","author":"Burbos","year":"2007","journal-title":"J Obstet Gynaecol"},{"key":"R17-20250503","doi-asserted-by":"crossref","first-page":"m3773","DOI":"10.1136\/bmj.m3773","article-title":"Treatment of epithelial ovarian cancer.","volume":"371","author":"Kuroki","year":"2020","journal-title":"BMJ"},{"key":"R18-20250503","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/bjc.2012.516","article-title":"Evaluation of survival benefits by platinums and taxanes for an unfavourable subset of carcinoma of unknown primary: a systematic review and meta-analysis.","volume":"108","author":"Lee","year":"2013","journal-title":"Br J Cancer"},{"key":"R19-20250503","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.7314\/APJCP.2014.15.4.1581","article-title":"Docetaxel and cisplatin in first line treatment of patients with unknown primary cancer: a multicenter study of the Anatolian Society of Medical Oncology.","volume":"15","author":"Demirci","year":"2014","journal-title":"Asian Pac J Cancer Prev"},{"key":"R20-20250503","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1056\/NEJMoa1500596","article-title":"PD-1 Blockade in tumors with mismatch-repair deficiency.","volume":"372","author":"Le","year":"2015","journal-title":"N Engl J Med"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000036796","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T00:24:55Z","timestamp":1746318295000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000036796"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,29]]},"references-count":20,"journal-issue":{"issue":"52","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000036796","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,29]]}}}